Fluadinazolam
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C19H17ClFN5 |
Molar mass | 369.83 g·mol−1 |
3D model (JSmol) | |
| |
|
Fluadinazolam is a benzodiazepine derivative developed in 1973, with sedative and anxiolytic effects.[1] It is a derivative of the never commercially marketed benzodiazepine adinazolam and has similarly been sold as a designer drug.[2]
See also
References
- ^ US 3957761, Gall M, Hester JB, "Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][1]benzodiazepines and intermediates", issued 18 May 1976, assigned to Pharmacia and Upjohn
- ^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals. 14 (8). Basel, Switzerland: 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.
Categories:
- Articles with short description
- Short description matches Wikidata
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Designer drugs
- GABAA receptor positive allosteric modulators
- Fluoroarenes
- Heterocyclic compounds with 3 rings
- Nitrogen heterocycles
- Chloroarenes
- All stub articles
- Nervous system drug stubs